Business
Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors
Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors.
About this update from Cellev8 Nutrition Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Cellev8 Nutrition Welcomes Dr. Guangshuo \"Alan\" Zhu, MD to Its Board of Directors\r\n \r\n \r\n\r\n\r\nCellev8 Nutrition Welcomes Dr. Guangshuo \"Alan\" Zhu, MD to Its Board of Directors\r\n\r\n\r\n\r\n\r\n\r\nWELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the appointment of Dr. Guangshuo \"Alan\" Zhu, MD to its Board of Directors. Dr. Zhu brings decades of groundbreaking experience in cardiovascular medicine, translational research, and antioxidant biochemistry, including pioneering work in Superoxide Dismutase (SOD) - a core ingredient and biological inspiration behind Cellev8's advanced cellular protection technologies.\r\n As both a physician-scientist and biotechnology innovator, Dr. Zhu's career spans academia, clinical medicine, and venture investment in life sciences. His leadership and scientific acumen will help guide Cellev8's continued advancement in cellular rejuvenation, metabolic health, and antioxidant innovation.\r\n \"Dr. Zhu's extensive background in cardiovascular research and his deep expertise in oxidative stress and SOD biology align perfectly with Cellev8's mission to redefine how we protect and energize human cells,\" said Michael Ferraro, CEO of Cellev8 Nutrition Inc. Dr. Zhu's experience with SOD spans more than 20yrs of authoring or co-authoring research and studies about the significance of SOD in the human body and once we disclosed to him our product and transport method to get SOD back into the body and combined it with other ingredients to create the ultimate supplements he agreed to come on board to help maximize efficacy with athletes and our more than 60 professional teams as well as getting the products into the mainstream public market. \"His addition to our Board strengthens our scientific foundation and our strategic roadmap for global expansion.\"\r\n About Dr. Guangshuo \"Alan\" Zhu, MD\r\n Dr. Zhu served as former Lab Director at the Cardiovascular Physiology and Hemodynamic Core Laboratory at Johns Hopkins University School of Medicine, where his research focuses on developing novel treatments for cardiovascular disease and exploring mitochondrial and oxidative mechanisms in cardiac function.\r\n He is also Adjunct Faculty...